Your browser doesn't support javascript.
loading
Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns.
Zhao, Ya'ning; Bai, Jun; Wang, Xi; Zhang, Yaoren; Yan, Xiaohong; Qi, Jun'an; Xia, Xueyan; Feng, Yuansong; Duan, Baojun.
Afiliación
  • Zhao Y; Department of Medical Oncology of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
  • Bai J; Department of Medical Oncology of Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.
  • Wang X; Department of Medical Oncology of Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.
  • Zhang Y; Department of Ultrasonography of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
  • Yan X; Department of Medical Oncology of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
  • Qi J; Department of Hepatobiliary Surgery of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
  • Xia X; Department of Medical Oncology of Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.
  • Feng Y; Department of Medical Oncology of Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.
  • Duan B; Department of Medical Oncology of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
J Cancer ; 15(8): 2193-2205, 2024.
Article en En | MEDLINE | ID: mdl-38495485
ABSTRACT
With the development of guidance technology and ablation equipment, ablative procedures have emerged as important loco-regional alternatives to surgical resection for recurrent hepatocellular carcinoma (rHCC) patients. Currently, ablation modalities used in clinical practice mainly include radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), cryoablation (CRA), high-intensity focused ultrasound (HIFU), and irreversible electroporation (IRE). Accumulated comparative data of ablation versus surgical resection reveal noninferior responses and outcomes but superior adverse effects. Moreover, studies demonstrate that ablation may serve as an excellent procedure for rHCC given its exact minimal invasiveness and immune modulation. We focus on the current status of ablation in clinical practice for rHCC and discuss new research in the field, including ablation combined with these other modalities, such as targeted therapy and immunotherapy.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia